BiotechTube
Home/DelSiTech/Sari Häkkinen
SH

Sari Häkkinen

Chief Development Officer

DelSiTech

Therapeutic Areas

Metabolic DiseasePain

DelSiTech Pipeline

DrugIndicationPhase
Lead long-acting injectable assetsMetabolic disease and painNot Specified

Leadership Team at DelSiTech

MH
Martti Hedman
Interim Chief Executive Officer
KR
Kristian Rantala
Chief Financial Officer
FD
Frederic Dargelas
Chief Commercial Officer
View full DelSiTech profile